Shanghai ChemPartner closes deal with Quantum

China |  News | 0 Comment | 17 Aug, 2018

Shanghai ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and development services, recently announced the closure of the merger dea...Read more

Blueberry Therapeutics raises £10M funding to develop nanomedicines

China |  News | 0 Comment | 16 Aug, 2018

Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, has successfully com...Read more

Crown Bioscience to expand GEM selection through new collaboration

China |  News | 0 Comment | 16 Aug, 2018

Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research...Read more

Haisco to make $10M equity investment in Pneuma Respiratory

China |  News | 0 Comment | 14 Aug, 2018

Haisco Pharmaceutical Group Co Ltd, a China-based company focused on the research and development and marketing of therapeutic drugs, has agreed to make a $10 million equity investment in P...Read more

Synergy Pharmaceuticals inks deal with Luxion Pharma

China |  News | 0 Comment | 10 Aug, 2018

Synergy Pharmaceuticals  recently announced that the company has entered into a license agreement with Luoxin Pharmaceutical Group, Shandong  providing Luoxin with exclusive right...Read more

JHL Biotech Gets Positive CHMP Scientific Advice for Bevacizumab Biosimilar

China |  News | 0 Comment | 10 Aug, 2018

JHL Biotech has received a positive Scientific Advice from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) related to the EU approval pathwa...Read more

Biotech Firm EdiGene Raises $15 Million in Series pre-B Financing

China |  News | 0 Comment | 09 Aug, 2018

EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the suc...Read more

Scientists use nanoparticles to detect deep-tissue cancers

China |  News | 0 Comment | 09 Aug, 2018

Australian and Chinese scientists have developed a method using coded nanoparticles to detect and help diagnose disease.    The research team from Macquarie University and Fudan...Read more

WHO HCV Guidelines recommends Ascletis' Ravidasvir

China |  News | 0 Comment | 09 Aug, 2018

Ascletis Pharma Inc  announced  Ravidasvir is recommended by the World Health Organization (WHO) Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepat...Read more

I-Mab Biopharma, MorphoSys declares China IND Submission of monoclonal antibody

China |  News | 0 Comment | 08 Aug, 2018

On August 8, 2018, Beijing time I-Mab Biopharma ("I-Mab"), a Shanghai-based biotech company focused on innovative biologics in oncology and autoimmune disease, and German biopharma company ...Read more

Pfizer's Innovative drug IBRANCE gets China approval

China |  News | 0 Comment | 08 Aug, 2018

Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbociclib) on July 31st, the first cyclin-dependent Kinase 4/6 (CDK4/6) inh...Read more

Glenmark signs licence deal with Harbour BioMed

China |  News | 0 Comment | 07 Aug, 2018

Glenmark Pharmaceuticals S.A. and Harbour BioMed have entered into an exclusive license agreement for the Greater China territory to develop, manufacture and commercialize GBR 130...Read more

CureGenetics secures $17 M in Series A Financing

China |  News | 0 Comment | 07 Aug, 2018

Cure Genetics Co., Ltd., a biotechnology company dedicated to the development of life-saving transformative medicines and molecular diagnostics using best-in-class gene editing technologies...Read more

IMPACT Therapeutics Raises $30 M in Series C Financing

China |  News | 0 Comment | 06 Aug, 2018

IMPACT Therapeutics a China-based clinical-stage biopharmaceutical company dedicated to the discovery and development of "best-in-class" medicine for the treatment of cancer and other life-...Read more

Laekna acquires exclusive rights for two oral Akt inhibitors

China |  News | 0 Comment | 06 Aug, 2018

Laekna Inc., a biotechnology company headquartered in Shanghai has announced the signing of an agreement with Novartis Pharma AG for exclusive global rights to develop and commercialize two...Read more

Legend Capital co-invests $293M in Chinese DMC

China |  News | 0 Comment | 02 Aug, 2018

Legend Capital, the venture and growth capital arm of China’s Legend Holdings Ltd, has co-led an RMB2 billion ($293 million) investment in Chinese Diagnostics Medical Corporation by j...Read more

Chinese medical solution provider raises $146.8M

China |  News | 0 Comment | 02 Aug, 2018

Chinese medical solution provider Medlinker has raised a RMB1 billion ($146.8 million) series D round led by China Capital Zhongcai Fund, an industrial fund management company jointly spons...Read more

Ascletis' NDA for its all-oral HCV treatment accepted by CFDA

China |  News | 0 Comment | 01 Aug, 2018

Ascletis has received the acceptance letter from the China Food and Drug Administration (CFDA) for Ravidasvir (RDV) new drug application (NDA). Ravidasvir in combination with Ganovo (RDV/D...Read more